Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Safety and Efficacy of Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.
Summary
The aim of the study is to evaluate the safety and efficacy of oral ecnoglutide tablets in Chinese participants with overweight or obesity
Official title: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Safety and Efficacy of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2026-11-10
Completion Date
2028-01-28
Last Updated
2026-11-10
Healthy Volunteers
No
Conditions
Interventions
ecnoglutide tablet
oral tablet
placebo with matching dosage
oral tablet
Locations (1)
The First Affiliated Hospital of Henan University of Science & Technology
Luoyang, Henan, China